查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
第一线医疗团队如何有效应对罕见疾病领域：Expert Q&A
市场调查报告书
商品编码
1773146

第一线医疗团队如何有效应对罕见疾病领域：Expert Q&A

Expert Q&A: How Field Medical Teams Effectively Traverse Rare Disease Terrain
出版日期: | 出版商: FirstWord Group | 英文 | 商品交期: 最快1-2个工作天内

价格
简介目录

第一线医疗团队的任务是弥合前沿科学与临床实践之间的差距，尤其是在复杂的罕见疾病领域。

这些疾病带来了独特的挑战，包括资料有限、患者群体规模小且地理分布分散，以及未满足的医疗需求巨大。对第一线医疗专业人员来说，这意味着要应对科学上的不确定性，与专家建立深厚的关係，并担任倡议者。

FirstWord访问了Kyowa Kirin北部群聚医疗主管 Gillian Logan，探讨了一线医疗团队如何应对罕见疾病领域的挑战。

关键问题：

  • 第一线医疗团队在与罕见疾病领域的医疗专业人员（HCP）合作时面临的最紧迫挑战是什么？
  • 协和麒麟如何客製化其医疗事务策略以满足罕见疾病族群的独特需求？
  • RWE 在塑造罕见疾病第一线医疗活动中扮演什么角色？
  • 协和麒麟的第一线医疗团队如何平衡科学交流需求与罕见疾病照护的情感和倡导面向？
  • 哪些工具和技术对支援罕见疾病第一线医疗团队最有效？
  • 如何确保不同地区和罕见疾病适应症之间科学交流的一致性和品质？
  • 协和麒麟的第一线医疗团队如何与病人倡导团体合作并直接与病人合作？
  • 如何将病患的声音融入第一线医疗策略和训练中？
  • 与一般疾病领域的专业人员相比，罕见疾病第一线医疗专业人员需要哪些能力和训练？
  • 预见哪些未来创新和趋势将塑造罕见疾病第一线医疗保健？

研究方法

檔案报告是基于独立而简洁的分析，这些分析源自于专有的产业研究以及对产业意见领袖的深入访谈。报告深入分析了製药企业高管需要了解的关键趋势和市场发展，以应对即将到来的机会和挑战。每份报告的重点都基于二手文献综述和已确定的知识差距。基于这些初步研究，制定了基于证据、专家指导的讨论指南，以确保研究能够解答最重要的问题。此外，制定了严格的筛选标准，以确保受访者拥有就该主题发言所需的经验、知识和资格。

报告有何独特之处？

FirstWord Reports 是值得信赖的行业领导者，致力于製药业，为生物製药专业人士和决策者提供详细且可操作的见解。深厚的行业知识使能够提供相关且有价值的见解，有助于的客户掌握新兴趋势并有效解决复杂挑战。报告以广泛的研究成果以及来自顶尖专家和关键意见领袖（KOL）的独立客观见解为后盾，提供所需的准确性和可靠性。透过独家访谈和资料，加上持续的市场监测，可全面了解市场动态。报告涵盖 40 多个活跃的疾病领域，汇集了包括关键意见领袖（KOL）洞察和定量医生调查在内的医生情报，以及行业专家对医疗事务、数位健康、销售与营销、市场准入及其他领域问题的看法，助做出更明智的资料驱动决策，在快速变化的行业中保持竞争力。

简介目录

Field medical teams bridge the gap between cutting-edge science and clinical practice, especially in the complex area of rare diseases.

These conditions present unique challenges, such as limited data, small and geographically dispersed patient populations, and a high unmet medical need. For field medical professionals, this means navigating scientific uncertainty, building deep relationships with specialists, and serving as advocates.

FirstWord spoke with Gillian Logan, head of medical, northern cluster at Kyowa Kirin, to discuss how field medical teams tackle the challenges within the rare disease space.

Key Questions Answered:

  • What are the most pressing challenges field medical teams face when engaging with HCPs in the rare disease space?
  • How does Kyowa Kirin tailor its medical affairs strategy to address the unique needs of rare disease communities?
  • What role does RWE play in shaping field medical activities for rare diseases?
  • How do field medical teams at Kyowa Kirin balance the need for scientific exchange with the emotional and advocacy aspects of rare disease care?
  • What tools or technologies have proven most effective in supporting field medical teams in rare disease settings?
  • How do you ensure consistency and quality in scientific communication across different regions and rare disease indications?
  • Can you share examples of how Kyowa Kirin's field medical teams collaborate with patient advocacy groups or directly with patients?
  • How do you incorporate the patient voice into field medical strategies and training?
  • What specific competencies or training are essential for field medical professionals working in rare diseases compared with more common conditions?
  • What innovations or trends do you foresee shaping the future of field medical affairs in rare diseases?

Methodology:

Dossier reports are developed from independent and concise analysis derived from original industry surveys and in-depth interviews with industry thought leaders. Reports analyse in detail significant developments and market trends that pharma executives need to understand if they are to manage the opportunities and challenges that lie ahead. The focus of each report is defined by a review of the secondary literature and any knowledge gaps identified. Based on this initial research, an evidence-based and expert-informed discussion guide is developed to ensure the research answers the most critical questions. Additionally, robust screening criteria are established to ensure that those interviewed are qualified in terms of their experience, knowledge and stature to speak on the topic.

What makes our reports different?

FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.